IgG antibodies produced during subcutaneous allergen immunotherapy mediate inhibition of basophil activation via a mechanism involving both FcγRIIA and FcγRIIB
- 4 May 2010
- journal article
- Published by Elsevier BV in Immunology Letters
- Vol. 130 (1-2), 57-65
- https://doi.org/10.1016/j.imlet.2009.12.001
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Fc Optimization of Therapeutic Antibodies Enhances Their Ability to Kill Tumor CellsIn vitroand Controls Tumor ExpansionIn vivovia Low-Affinity Activating Fcγ ReceptorsCancer Research, 2007
- Monoclonal antibodies capable of discriminating the human inhibitory Fcγ‐receptor IIB (CD32B) from the activating Fcγ‐receptor IIA (CD32A): biochemical, biological and functional characterizationImmunology, 2007
- Chimeric Human Fcγ–Allergen Fusion Proteins in the Prevention of AllergyImmunology and Allergy Clinics of North America, 2007
- Selective dysregulation of the FcγIIB receptor on memory B cells in SLEThe Journal of Experimental Medicine, 2006
- Fcγ Receptors: Old Friends and New Family MembersImmunity, 2006
- Mechanisms of immunotherapyJournal of Allergy and Clinical Immunology, 2004
- Allergen immunotherapy for asthmaPublished by Wiley ,2003
- Activating and inhibitory signaling in mast cells: New opportunities for therapeutic intervention?Journal of Allergy and Clinical Immunology, 2000
- Reconstituted Killer Cell Inhibitory Receptors for Major Histocompatibility Complex Class I Molecules Control Mast Cell Activation Induced via Immunoreceptor Tyrosine-based Activation MotifsPublished by Elsevier BV ,1997
- PROPHYLACTIC INOCULATION AGAINST HAY FEVERThe Lancet, 1911